Trial
NCT04729348
Pembrolizumab And Lenvatinib In Leptomeningeal Metastases
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Massachusetts General Hospital
Collaborators
Merck Sharp & Dohme LLC
Condition
Solid Tumor
Intervention
Pembrolizumab
Why stopped
Planned interim analysis
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-25